Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 94.26 USD 0.63%
Market Cap: 139.4B USD

BSX's latest stock split occurred on Nov 6, 2003

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

The adjusted shares began trading on Nov 6, 2003. This was BSX's 2nd stock split, following the previous one in Dec 1, 1998.

Last Splits:
Nov 6, 2003
2-for-1
Dec 1, 1998
2-for-1
Pre-Split Price
N/A
Post-Split Price
36.1
Before
After
Last Splits:
Nov 6, 2003
2-for-1
Dec 1, 1998
2-for-1

Boston Scientific Corp
Stock Splits History

BSX Stock Splits Timeline
Nov 6, 2003
Nov 6, 2003
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
36.1
Before
After
Dec 1, 1998
Dec 1, 1998
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
36.1
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 7, 2025
BioNexus Gene Lab Corp
NASDAQ:BGLC
1-for-10
/10
0.235 2.35 USD 2.92 2.92 USD
Apr 7, 2025
Alligator Bioscience AB
STO:ATORX
1-for-1000
/1000
0.0055 5.5 SEK 5.4 5.4 SEK
Apr 7, 2025
Treasure Global Inc
NASDAQ:TGL
1-for-50
/50
0.057 2.85 USD 2.8 2.8 USD
Apr 7, 2025
S
Safe & Green Development Corp
NASDAQ:SGD
105-for-100
x1.05
1.28 1.219 USD 1.14 1.14 USD
Apr 7, 2025
G
Ge-Shen Corporation Bhd
KLSE:GESHEN
959692-for-319897
x3.0000031260062
4.35 1.45 MYR 1.37 1.37 MYR
Load More

Boston Scientific Corp
Glance View

Economic Moat
Narrow
Market Cap
138.9B USD
Industry
Health Care

In the world of medical devices, Boston Scientific Corp. has carved out a significant niche, navigating the intersection of innovation and healthcare with precision. Founded in 1979, the company has built a robust reputation for developing a diverse range of products that address complex medical conditions. Boston Scientific operates through various segments, primarily focusing on interventional medical specialties that target areas such as cardiology, endoscopy, and neuromodulation. Through its relentless pursuit of innovation, the company continues to push boundaries, enhancing the diagnostic and therapeutic capabilities of physicians worldwide. The heartbeat of its operations lies in its extensive research and development endeavors, where cutting-edge technology meets advanced medical knowledge to produce life-enhancing solutions. At its core, Boston Scientific makes money by designing, manufacturing, and selling medical devices used in minimally invasive procedures. Its product portfolio includes solutions for coronary artery disease, heart rhythm disorders, peripheral artery disease, and many other critical ailments. By partnering with healthcare providers, Boston Scientific enables hospitals and clinics to offer high-quality, efficient care that caters to patient needs in a cost-effective manner. Revenue streams flow through direct sales channels and strategic partnerships across global markets, reflecting a combination of organic growth and strategic acquisitions. Moreover, the company actively reinvests in future technologies, ensuring its position as a pioneer in medical advancements while meeting the ever-evolving demands of the industry.

BSX Intrinsic Value
67.12 USD
Overvaluation 29%
Intrinsic Value
Price
Back to Top